Neurogenic cough.

Published

Journal Article (Review)

We review contemporary concepts of the pathophysiology of neurogenic cough, and its evaluation and treatment based on scientific publications addressing neurogenic cough. Neurogenic cough is thought to be the result of sensory neuropathy, most commonly idiopathic. Because it is principally a sensory phenomenon, clinical evaluation is challenging, the diagnosis most often being made by exclusion. Identification of motor paresis, either by laryngoscopy or laryngeal electromyography, may suggest the presence of sensory neuropathy. The utility of amitriptyline and gabapentin has been demonstrated in randomized clinical trials, and retrospective series and case reports have suggested efficacy of pregabalin, baclofen, and botulinum toxin. Sensory neuropathy appears to be an important cause of chronic refractory cough, and appears amenable to treatment with a variety of pharmacologic agents.

Full Text

Duke Authors

Cited Authors

  • Altman, KW; Noordzij, JP; Rosen, CA; Cohen, S; Sulica, L

Published Date

  • July 2015

Published In

Volume / Issue

  • 125 / 7

Start / End Page

  • 1675 - 1681

PubMed ID

  • 25647253

Pubmed Central ID

  • 25647253

Electronic International Standard Serial Number (EISSN)

  • 1531-4995

Digital Object Identifier (DOI)

  • 10.1002/lary.25186

Language

  • eng

Conference Location

  • United States